drugset / Trial / NCT07519109

Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.

NCT07519109

Phase 1 Recruiting 60 enrolled CSPC Ouyi Pharmaceutical Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a randomized, double-blind, active drug- and placebo-controlled, dose-escalation clinical study conducted in patients scheduled to undergo abdominal surgery. It aims to evaluate the tolerability, safety, pharmacokinetics, and efficacy of SYH9089 Injection for postoperative analgesia in these patients.

Timeline

Start
2026-03-30
Primary completion
2026-12-31
Completion
2027-03-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified Other
Subject SYH9089 Unknown Topical

Indications

No indication recorded.